Device
Sodium MRI
Sodium MRI is a medical device with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
60%
Ph phase_2
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(1)
Other(1)
Detailed Status
unknown1
Active, not recruiting1
Completed1
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
unknown120%
active_not_recruiting120%
completed120%
recruiting120%
not_yet_recruiting120%
Recent Activity
2 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable
Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET
NCT07100470
active_not_recruitingphase_2
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy
NCT04053842
recruitingnot_applicable
Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques
NCT06016075
completed
Dyspnea Assessment in Hemodialysis Patients
NCT03773991
unknownnot_applicable
Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral Sclerosis
NCT02874209
Clinical Trials (5)
Showing 5 of 5 trials
NCT07100470Not Applicable
Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET
NCT04053842Phase 2
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy
NCT06016075Not Applicable
Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques
NCT03773991
Dyspnea Assessment in Hemodialysis Patients
NCT02874209Not Applicable
Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral Sclerosis
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5